REQUEST A DEMO
Total
USD $0.00
Search more companies

Jm Sante Pharma Sp. z o.o. (Poland)

Main Activities: Dog and Cat Food Manufacturing
Secondary Activities: Other Animal Food Manufacturing | Pharmaceutical Preparation Manufacturing | Soap and Other Detergent Manufacturing | Toilet Preparation Manufacturing | Medical Equipment and Supplies Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Wholesale Trade Agents and Brokers
Full name: Jm Sante Pharma Sp. z o.o. Profile Updated: March 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Jm Sante Pharma Sp. z o.o. is a company based in Poland, with its head office in Sosnowiec. It operates in the Dog and Cat Food Manufacturing sector. The company was established on August 05, 2021. From the latest financial highlights, Jm Sante Pharma Sp. z o.o. reported a net sales revenue increase of 60.82% in 2023. There was a total growth of 23.66% in Jm Sante Pharma Sp. z o.o.’s total assets over the same period. In 2023, Jm Sante Pharma Sp. z o.o.’s net profit margin increased by 5.95%.

Headquarters
Ul. Krzysztofa Kamila Baczynskiego 25A
Sosnowiec; Slaskie; Postal Code: 41-203

Contact Details: Purchase the Jm Sante Pharma Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Jm Sante Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Jm Sante Pharma Sp. z o.o. report to view the information.
Incorporation Date:
August 05, 2021
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
27.4%
Purchase this report to view the information.
27.4%
Purchase this report to view the information.
19.89%
Purchase this report to view the information.
17.4%
Company Performance
Financial values in the chart are available after Jm Sante Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
60.82%
Total operating revenue
60.86%
Operating profit (EBIT)
238.49%
EBITDA
158.79%
Net Profit (Loss) for the Period
244.98%
Total assets
23.66%
Total equity
69.37%
Operating Profit Margin (ROS)
6.09%
Net Profit Margin
5.95%
Return on Equity (ROE)
20.85%
Quick Ratio
0.52%
Cash Ratio
0.44%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?